| Year | Federal $ expended | Auditor | Opinion | Flags |
|---|---|---|---|---|
| 2025 | $16.7M | Deloitte & Touche LLP | Unmodified (clean) | Low-risk auditee |
| 2024 | $23.4M | Deloitte & Touche, LLP | Unmodified (clean) | Low-risk auditee |
| 2023 | $50.4M | Deloitte | Unmodified (clean) | Low-risk auditee |
| 2022 | $31.3M | Deloitte | Unmodified (clean) | Low-risk auditee |
| Program | Agency | Expended | Major program | Findings |
|---|---|---|---|---|
| Coronavirus State and Local Fiscal Recovery Funds via MA Technology Collaborative | Treasury | $2.7M | No | 0 |
| Substance Abuse and Mental Health Services Projects of Regional and National Significance | HHS | $1.9M | Yes | 0 |
| DRUG Use and Addiction Research Programs | HHS | $1.5M | Yes | 0 |
| Crime Victim Assistance via Massachusetts Office of Victim Assisstance | Justice | $1.0M | No | 0 |
| Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders | HHS | $955K | Yes | 0 |
| Cardiovascular Diseases Research | HHS | $775K | Yes | 0 |
| National and State Tobacco Control Program | HHS | $746K | Yes | 0 |
| Aging Research | HHS | $670K | Yes | 0 |
| Opioid STR via Massachusetts DPH | HHS | $499K | No | 0 |
| Coronavirus State and Local Fiscal Recovery Funds | Treasury | $451K | No | 0 |